DNOWDNOW Inc.

$15.57+3.1% 1Y

Is the business good?

Watch

More warning than reassurance: 3 of 9 health tests passed and margins compressing.

2 to watch, 2 without data
Fundamental health (F-score)3 / 9SEC EDGAR · Dec 31, 2025

Weak, deteriorating fundamentals. Nine pass/fail tests of year-over-year health from the filings.

Margin direction, 3 years−11.2 ptsderived

Operating margin has narrowed over the past few years, profitability per dollar of sales is eroding.

Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.

How good a business is DNOW?

DNOW Inc. earns −6.6% on the capital it employs against a 9.0% cost of capital, so growth costs more than it returns.

−6.6%

Return on invested capital · cost of capital 9.0% · 16 points below what the capital costs: growth destroys value

Operating margin
−5.0%

Operating margin · Industrial Distribution median 8.3% · 12 months to Q2 2026

Share count, year on year
+72%

Share count, year on year · shareholders own a smaller slice than a year ago

Gross margin
15%

Gross margin

Operating margin by fiscal year
YearOperating margin
FY2020−26%
FY20210.55%
FY20226.1%
FY20236.2%
FY20244.6%
FY2025−3.3%
Details›
Gross margin12 months to Q2 2026
15%
Operating margin12 months to Q2 2026
−5.0%
Net margin12 months to Q2 2026
−4.9%
Free cash flow margin
3.3%
Revenue, trailing twelve months
$4.08B
Free cash flow, trailing twelve months
$136M
Net income, trailing twelve months
−$201M
Return on invested capitaloperating profit after tax ÷ debt + equity − cash
−6.6%

Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.